Annual Report 2017

Organization

As of March 31, 2018

President:
Hitoshi Nakagama
- Director:
  Atsushi Ochiai
- Group for Clinical Research
  - Division of Experimental Therapeutics
- Group for Translational Research
  - Division of Biomarker Discovery
  - Division of Translational Genomics
  - Division of Cancer Immunology
  - Division of Clinical Pharmacology and Translational Research
  - Division of Innovative Pathology and Laboratory Medicine
- Group for Innovative Cancer Treatment
  - Division of Pathology
  - Divison of Developmental Therapeutics
  - Division of Cancer Immunotherapy
  - Division of Psycho-Oncology
  - Division of Supportive Care Research
- Group for Innovative Diagnostic and Therapeutic Device
  - Division of Functional Imaging
  - Division of Radiation Oncology and Particle Therapy
  - Division of BNCT Medical Research
  - Division of Science and Technology for Endoscopy
  - Division of Surgical Technology
- - Section of Experimental Animals
  - Section of Support of Animal Experimentation